At Sydney Vital, we run top-up scholarship awards for researchers who propose innovative and outstanding research projects. Our scholarship candidates look to improve examinations for early diagnoses, treatments and quality of life.
Sydney Cancer Conference 2018 – Closed
This will be the sixth Sydney Cancer Conference and is focusing on the theme of ‘Bridging research and practice,’ the program features all areas of cancer research – basic biomedical, public health, clinical and psychosocial – making the latest information and research available to delegates.
Sydney vital will be supporting up to ten attendees and applications are invited from suitably qualified researchers. Our aim is to encourage outstanding PhD students, ECRs, researchers and clinicians from within the Sydney Vital network and institutions to present their scientific research progress at national or international conferences.
Submission Guidelines
Applications must complete the Sydney Vital Registration Support Form for the SCC2018 and must be submitted as a single PDF attachment in an email to [email protected]. Please use the following naming convention:
LastName_FirstName_SCC2018
Once approved, Sydney Vital will complete payment of the successful applicants’ registration fee. Please note, we will not reimburse any payments that have been made prior to applying for registration support.
Applications will close on Friday 25th May 2018. Sydney Vital Centre Manager, Suzie Nguyen, can be contacted on 9926 4726 or at [email protected] to assist with any queries.
Research Fellowship in the area of Nanotechnology – Closed
Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.
This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.
Key Dates
Closing Date for Applications: Friday 13th April 2018.
Please read on: Flagship 3_ Nanotechnology_Research Fellowship_ Guidelines_2018
Please let us know if you have any further questions.
Email: [email protected] for general information regarding your application submission.
Email: Alexander Engel: [email protected] for specific question regarding the Flagship 3.
Research Fellowship in the area of Nanotechnology – CLOSED
Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.
This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.
Key Dates
Call for Applications: Tuesday 31st January 2017
Closing Date for Applications: Tuesday 27th February 2017
Announcement of Outcome aim at: Wednesday 15th March 2017
Please read on: Flagship3_ Nanotechnology_Research Fellowship_ Application_2017-31012017
Please let us know if you have any further questions.
Email: [email protected] for general information regarding your application submission.
Email: Alexander Engel: [email protected] for specific question regarding the Flagship 3.
Funding Awarded By Sydney Vital
The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.
| # | Awardee | Institution | Supervisor | Research Title | Amount Awarded |
|---|---|---|---|---|---|
| 1 | Jerikho Bulanadi | Kolling Institute of Medical Research | Prof Ross Smith | Chemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery. | $15,000 |
| 2 | Emma Colvill | Sydney University Medical School | Prof Paul Keall | The bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer | $15,000 |
| 3 | Grace Gifford | Haematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, Sydney | Dr William Stevenson | Gene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making. | $15,000 |
| 4 | Dr Anthony Glover | Kolling Institute of Medical Research, Royal North Shore Hospital | Prof Stanley Sidhu | Noncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes. | $15,000 |
| 5 | Diana Hatoum | Faculty of Science, UTS Sydney | Dr Najah Nassif | A Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer. | $15,000 |
| 6 | Samuel Brennan | Faculty of Science, UTS Sydney | Dr Rose Martiniello-Wilks | Development of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis. | $15,000 |
| 7 | Ben Harris | Sydney Medical School, University of Sydney | Dr Kellie Charles | Investigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation. | $15,000 |
| 8 | Adrian Lee | Bill Walsh Translation Cancer Research Laboratory, Kolling Institute | Dr Viive Howell | "Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with glioblastoma multiforme?" | $15,000 |
| 9 | Jaynish Shah | Sydney Medical School, University of Sydney | Prof Deborah Marsh | Investigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key? | $15,000 |
Research Scholarship Awards Round 3 – CLOSED
Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $15,000 each for one year to students, preclinical and clinical researchers working in the area of Translational Cancer Research. These awards are to be used to support the research and are to be spent at the discretion of the student and their supervisor(s).
Key Dates for Round 3
Call for Applications: 1 September 2015
Closing Date for Applications: 1 October 2015
Announcement of Outcome: 1 November 2015
Sydney Vital_Research Scholar Award_Guidelines_Round 3_2015
Implementation Research Pilot projects – CLOSED
CALL FOR EOI’S
Sydney Vital is calling for proposals for implementation research pilot projects via an Expression of Interests (EOI) process.
Sydney Vital will provide financial support for a number of implementation research projects in the 2015 calendar year.
This expression of interest (EOI) may include (but are not limited to) the following themes:
• Educate Sydney Vital member network on implementation (T3) of evidence based supportive care strategies for cancer symptoms and treatment side effects.
• Develop Health Professional Education modules using e-learning techniques which can be made available to clinicians in NSW.
• Identify new clinical pathways or techniques based on the evidence based guidelines suitable for implementation
• Test methods for delivery of psychosocial support and reduction of treatment toxicity
• Evaluating new approaches to breast reconstruction and their impact on Quality of Life (QoL).
• Identify ways to improve management of survivorship issues in cancer patients.
• Test new methods of care or prognostic factors for patients with late stage cancer.
FUNDING AVAILABLE
Up to $25,000 in funding to support the undertaking of an implementation research project. The funding must be spent within 12 months of receiving the award. Management team may allocate funding to one or more projects.
Read More: Implementation Research_Seed Funding 2015_EOI
Closing Date for EOI’s: Friday, 5 June 2015
Supportive care, end stage tumour, and end-of life management – CLOSED
CALL FOR EOI’S FOR PILLAR LEADERS
Sydney Vital is seeking 2 individuals to act as leader for Pillar 4:
“Supportive care, end stage tumours, and end-of life management”. The Pillar’s aims are deliberately broad to allow scope to explore and exploit strengths within the partner organisations. The Pillar provides base funding of $10 k p.a. (which can be further leveraged) to support activities to bring Pillar members together to develop new programs of research, both basic science and clinical, and to expand networks and collaborations. Ideally, the Pillars would have outputs that impact on the T1, T2 and T3 domains of translational research as defined by the CINSW, or the Sydney Vital Flagship Programs 1, 2, or 3 (www.sydneyvital.org.com). The Pillar leader is ideally an early to mid-career researcher who is currently developing their research portfolio.
Read More: Pillar 4 EOI_ 2015
Closing Date for EOI’s: Friday, 5th June 2015
Flagship 1 Seed Funding – CLOSED
The Sydney Vital Flagship 1 program has up to $25,000 available to encourage the development of new research ideas in preclinical studies of treatment-resistant cancers. Projects should concern
(i) new therapies for treatment-resistant cancers, or
(ii) the identification of new biomarkers of treatment resistance.
Applications are sought from Sydney Vital members for two 1-year grants of up to $12,000 each in either of the above areas. Each applicant may submit only one application in this funding round. These grants are not intended to support the extension or expansion of existing research projects, but are to seed new ideas, with the goal of generating data to a point where external funding may be sought.
Read More: Sydney Vital Flagship 1 SEED FUNDING
Closing date: Sunday, 17th May 2015
- 1
- 2
Recent Posts
Farewell from Sydney Vital Director Dale Bailey
Posted on June 30, 2021
Former fellows, where are they now? – Dr Wei Deng
Posted on June 15, 2021
Former fellows, where are they now? – A/Prof Haryana Dhillon